CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance gene editing technology by developing methods to insert large synthetic DNA sequences into mammalian genomes with high precision. Utilizing engineered viruses and advanced DNA assembly techniques, it seeks to improve applications in biomedical research and industrial biotechnology.
Gene editing has developed at breath-taking speed.
In particular CRISPR/Cas9 provides a tool-set thousands of researchers worldwide now utilize with unprecedented ease to edit genes, catalysing a broad range of biomedical and industrial applications.
Gene synthesis technologies producing thousands of base pairs of synthetic DNA have become affordable.
Current gene editing technology is highly effective for local, small genomic DNA edits and insertions.
To unlock the full potential of this revol…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
